ME-344: Phase I started

Marshall Edwards began an open-label, dose-escalation, U.S. Phase I trial to evaluate once-weekly 1.2, 2.5, 5, 10 and 20 mg/kg IV ME-344 for the first 3 weeks of a 28-day cycle in up to 24 patients. P...